Author:
M. Said Sameh,Quintana Eduard,F. Salhab Khaled
Abstract
Hypertrophic cardiomyopathy is a unique myocardial disorder that can present in all ages from neonate to adults and has strong genetic basis. Several key features characterize hypertrophic cardiomyopathy. These include: the presence of left ventricular hypertrophy that can not be explained by another etiology, and left ventricular outflow tract obstruction secondary to systolic anterior motion of the anterior mitral valve leaflet with varying degrees of mitral valve regurgitation. Surgical septal myectomy continues to be the standard line of treatment when medical therapy fails or become intolerable. We summarize in the current chapter the technical tips and pitfall of septal myectomy, its alternatives/adjuncts and its outcomes.
Reference31 articles.
1. Goodwin JF, Hollman A, Cleland WP, et al. Obstructive cardiomyopathy simulating aortic stenosis. British Heart Journal. 1960;22:403-414
2. Morrow AG, Brockenbrough EC. Surgical treatment of idiopathic hypertrophic subaortic stenosis: Technique and hemodynamic results of subaortic ventriculomyotomy. Annals of Surgery. 1961;154:181-189
3. Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. The Journal of Thoracic and Cardiovascular Surgery. 2011;142(6):e153-e203
4. Nishimura RA, Giuliani ER, Brandenburg RO, et al. Hypertrophic cardiomyopathy. In: Giuliani ER, Gersh BJ, McGoon MD, Hayes DL, Schaff HV, editors. Myocardial Disease: Mayo Clinic Practice of Cardiology. 3rd ed. St. Louis, MO: Mosby-Year Book; 1996. pp. 689-711
5. Said SM, Schaff HV. Surgical treatment of hypertrophic cardiomyopathy. Semin Thoracic Surg. 2014;25:300-309